Filing Details

Accession Number:
0001609351-17-000069
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-07 16:40:19
Reporting Period:
2017-07-05
Filing Date:
2017-07-07
Accepted Time:
2017-07-07 16:40:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609351 Spark Therapeutics Inc. ONCE Biological Products, (No Disgnostic Substances) (2836) 462654405
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1631262 D Jeffrey Marrazzo C/O Spark Therapeutics, Inc.
3737 Market Street, Suite 1300
Philadelphia PA 19104
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-07-05 5,669 $3.45 235,669 No 4 M Direct
Common Stock Disposition 2017-07-05 5,669 $65.00 230,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-07-05 5,669 $0.00 5,669 $3.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
327,071 2024-07-01 No 4 M Direct
Footnotes
  1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2016.
  2. This option was granted on July 2, 2014 and vests over four years, with 25% of the shares underlying the option vesting on May 24, 2015, and the remainder vesting quarterly thereafter.